Remote ischemic conditioning in ST-segment elevation myocardial infarction - an update.

Conditioning medicine Pub Date : 2018-08-01
Jun Chong, Heerajnarain Bulluck, En Ping Yap, Andrew Fw Ho, William A Boisvert, Derek J Hausenloy
{"title":"Remote ischemic conditioning in ST-segment elevation myocardial infarction - an update.","authors":"Jun Chong,&nbsp;Heerajnarain Bulluck,&nbsp;En Ping Yap,&nbsp;Andrew Fw Ho,&nbsp;William A Boisvert,&nbsp;Derek J Hausenloy","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Acute myocardial infarction (AMI) and the heart failure (HF) that often results are among the leading causes of death and disability in the world. As such, novel strategies are required to protect the heart against the detrimental effects of acute ischemia/reperfusion injury (IRI), in order to reduce myocardial infarct (MI) size and prevent the onset of HF. The endogenous cardioprotective strategy of remote ischemic conditioning (RIC), in which cycles of brief ischemia and reperfusion are applied to a tissue or organ away from the heart, has been reported in experimental studies to reduce MI size in animal models of acute IRI. In the clinical setting, RIC can be induced by simply inflating and deflating a cuff placed on the upper arm or thigh to induce brief cycles of ischemia and reperfusion, a strategy which has been shown to reduce MI size in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PPCI). The results of the ongoing CONDI2/ERIC-PPCI trial are eagerly awaited, and will provide definitive answers with regards to the cardioprotective effect and clinical outcome benefits of RIC in STEMI.</p>","PeriodicalId":72686,"journal":{"name":"Conditioning medicine","volume":"1 5","pages":"13-22"},"PeriodicalIF":0.0000,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191186/pdf/nihms-988793.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Conditioning medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Acute myocardial infarction (AMI) and the heart failure (HF) that often results are among the leading causes of death and disability in the world. As such, novel strategies are required to protect the heart against the detrimental effects of acute ischemia/reperfusion injury (IRI), in order to reduce myocardial infarct (MI) size and prevent the onset of HF. The endogenous cardioprotective strategy of remote ischemic conditioning (RIC), in which cycles of brief ischemia and reperfusion are applied to a tissue or organ away from the heart, has been reported in experimental studies to reduce MI size in animal models of acute IRI. In the clinical setting, RIC can be induced by simply inflating and deflating a cuff placed on the upper arm or thigh to induce brief cycles of ischemia and reperfusion, a strategy which has been shown to reduce MI size in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PPCI). The results of the ongoing CONDI2/ERIC-PPCI trial are eagerly awaited, and will provide definitive answers with regards to the cardioprotective effect and clinical outcome benefits of RIC in STEMI.

Abstract Image

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
st段抬高型心肌梗死的远程缺血调节研究进展。
急性心肌梗死(AMI)和心衰(HF)是世界上导致死亡和残疾的主要原因之一。因此,需要新的策略来保护心脏免受急性缺血/再灌注损伤(IRI)的不利影响,以减少心肌梗死(MI)的大小并防止HF的发生。内源性心脏保护策略的远端缺血调节(RIC),其中短暂的缺血和再灌注周期应用于心脏以外的组织或器官,已经在实验研究中报道,以减少急性IRI动物模型的心肌梗死大小。在临床环境中,RIC可以通过简单地对放置在上臂或大腿上的袖带充气和放气来诱导短暂的缺血和再灌注周期,这种策略已被证明可以减少st段抬高型心肌梗死(STEMI)患者接受原发性经皮冠状动脉介入治疗(PPCI)时心肌梗死的大小。正在进行的CONDI2/ERIC-PPCI试验的结果备受期待,并将为STEMI中RIC的心脏保护作用和临床结局益处提供明确的答案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Targeting leukotriene biosynthesis to prevent atherosclerotic cardiovascular disease. Commentary: Can astrocytic mitochondria therapy be used as antioxidant conditioning to protect neurons? Preclinical evaluation of circadian rhythm in ischemic stroke outcomes. Conditioning medicine for ischemic and hemorrhagic stroke. Mitochondria as the memory of preconditioning.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1